ISG15 Antikörper (N-Term)
Kurzübersicht für ISG15 Antikörper (N-Term) (ABIN387983)
Target
Alle ISG15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 31-61, N-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This ISG15 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-61 amino acids from the N-terminal region of human ISG15.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000. WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Haltbarkeit
- 6 months
-
-
-
: "ISG15 induction is required during L1-mediated colon cancer progression and metastasis." in: Oncotarget, Vol. 10, Issue 67, pp. 7122-7131, (2019) (PubMed).
: "ISG15 deficiency and increased viral resistance in humans but not mice. ..." in: Nature communications, Vol. 7, pp. 11496, (2018) (PubMed).
: "Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons." in: Journal of virology, (2016) (PubMed).
: "Oncogene-mediated regulation of p53 ISGylation and functions." in: Oncotarget, Vol. 5, Issue 14, pp. 5808-18, (2015) (PubMed).
: "Interferon stimulated gene 15 expression at the human embryo-maternal interface." in: Archives of gynecology and obstetrics, Vol. 290, Issue 4, pp. 783-9, (2014) (PubMed).
-
-
- ISG15 (ISG15 Ubiquitin-Like Modifier (ISG15))
-
Andere Bezeichnung
- ISG15
-
Hintergrund
- ISG15 is secreted from monocytes in response to type I interferons and causes natural killer (NK)-cell proliferation and an augmentation of non-MCH (major histocompatibility complex)-restricted cytotoxicity. Synthesis is stimulated by IFN-alpha or IFN-beta or IFN-omega , but not IFN-gamma . ISG15 expression is also induced by overexpression of interferon regulatory factors that participate in transcriptional regulation of IFN genes, and by influenza B virus. ISG15 is secreted also by cell lines of monocyte, T-lymphocyte, B-lymphocyte, human fibroblasts, and epithelial origins. The induction of terminal differentiation in human melanoma cells is associated with alterations in ISG15 expression. Enhancement of NK cell proliferation, augmentation of non-major histocompatibility complex-restricted cytotoxicity, and induction of IFN-gamma from T cells identify ISG15 as a member of the cytokine cascade and suggest that it may be responsible for amplifying and directing some of the immunomodulatory effects of IFN-alpha or IFN-beta. ISG15 has has also been shown to function intracellularly as a ubiquitin homolog.
-
Molekulargewicht
- 17888
-
Gen-ID
- 9636
-
NCBI Accession
- NP_005092
-
UniProt
- P05161
Target
-